 Patients treated with Vitamin K antagonists VKA or direct oral anticoagulants as Rivaroxaban, Apixaban, Edoxaban or Dabigatran, who experience severe bleeding andor need urgent interventionsoperations that cannot wait are included in this registry, or during emergency operations. 